All Stories

  1. Modeling of restenosis of main arteries after the intravascular stenting interventions

    Article • Science and Innovations in Medicine, March 2021, FSBEI of Higher Education SamSMU of Ministry of Health of the Russian Federation

    Dr GIUSEPPE G GALATI

  2. Renal protection: a leading mechanism for cardiovascular benefit in patients treated with SGLT2 inhibitors

    Article • Heart Failure Reviews, September 2020, Springer Science + Business Media

    Dr GIUSEPPE G GALATI

  3. Pathophysiology and management of recreational drug-related acute coronary syndrome: ANMCO position statement

    Article • Journal of Cardiovascular Medicine, August 2020, Wolters Kluwer Health

    Dr GIUSEPPE G GALATI

  4. The interplay between cardiology and diabetology: a renewed collaboration to optimize cardiovascular prevention and heart failure management

    Article • European Heart Journal - Cardiovascular Pharmacotherapy, May 2020, Oxford University Press (OUP)

    Dr GIUSEPPE G GALATI

  5. Myocardial Fibrosis in End-Stage HCM

    Article • Circulation Heart Failure, September 2016, Wolters Kluwer Health

    Dr GIUSEPPE G GALATI

  6. Myocardial amyloid infiltration: a less than expected homogeneous process

    Article • Heart, July 2014, BMJ

    Dr GIUSEPPE G GALATI

  7. The difficult diagnosis of isolated cardiac sarcoidosis: usefulness of an integrated MRI and PET approach

    Article • Heart, July 2013, BMJ

    Dr GIUSEPPE G GALATI